Evidence map›Paper›PMID 37240381›Full record

ArticleInternational journal of molecular sciences2023

Characterization of Disease Resistance Induced by a Pyrazolecarboxylic Acid Derivative in

Michiko Yasuda, Moeka Fujita, Khamsalath Soudthedlath, Miyuki Kusajima, Hideki Takahashi, Tomoya Tanaka, Futo Narita, Tadao Asami, Akiko Maruyama-Nakashita, Hideo Nakashita

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Enhanced disease resistance againstJournal of pesticide science · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Michiko YasudaPlant Acquired Immunity Research Unit, RIKEN Advanced Science Institute, Wako 351-0198, Japan.ORCID 0000-0003-2397-9621
Moeka FujitaDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui 910-1195, Japan.
Khamsalath SoudthedlathGraduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka 819-0395, Japan.
Miyuki KusajimaGraduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.ORCID 0000-0003-4151-6698
Hideki TakahashiGraduate School of Agricultural Science, Tohoku University, Sendai 980-8572, Japan.ORCID 0000-0001-5398-1867
Tomoya TanakaDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui 910-1195, Japan.
Futo NaritaDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui 910-1195, Japan.
Tadao AsamiGraduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
Akiko Maruyama-NakashitaGraduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka 819-0395, Japan.ORCID 0000-0002-3240-2843
Hideo NakashitaPlant Acquired Immunity Research Unit, RIKEN Advanced Science Institute, Wako 351-0198, Japan.
Fukui Prefectural University · JPKyushu University · JPRIKEN Advanced Science Institute · JPThe University of Tokyo · JPTohoku University · JP

Funding

Japan Society for the Promotion of Science 18K05656Japan Society for the Promotion of Science 19J14665
6 · The paper itself

Abstract

Systemic acquired resistance (SAR) is a potent innate immunity system in plants that is induced through the salicylic acid (SA)-mediated signaling pathway. Here, we characterized 3-chloro-1-methyl-1

Indexed as

ArabidopsisArabidopsis ProteinsDisease ResistanceGene Expression Regulation, PlantHumansMutationPlant DiseasesPseudomonas syringaeSalicylic AcidSignal TransductionArabidopsis ProteinsSalicylic Aciddiseasephytohormonesplant activatorsalicylic acidsystemic acquired resistance

Identifiers

PMID37240381
PMCPMC10219097
OpenAlexW4377291401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.